Causal network perturbations for instance-specific analysis of single cell and disease samples

Kristina L Buschur1,2, Maria Chikina1, Panayiotis V Benos1

  • 1Department of Computational and Systems Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15260, USA.

Abstract

Insights

This study introduces sample-specific network perturbation analysis (ssNPA), a novel method for identifying disease mechanisms by analyzing gene network deregulation. ssNPA outperforms existing approaches in sample subtyping and reveals significant survival differences in patient clusters.

Area of Science:

  • Genomics
  • Systems Biology
  • Computational Biology

Background:

  • Complex diseases arise from disruptions in multiple biological pathways.
  • Characterizing these pathway perturbations in individual patients is crucial for personalized medicine.
  • Current methods often overlook data dependencies and pathway limitations.

Purpose of the Study:

  • To develop a novel computational approach for subtyping samples based on gene network deregulation.
  • To address limitations of existing methods that rely on external databases for pathway analysis.
  • To improve the identification of disease mechanisms for enhanced diagnosis and treatment.

Main Methods:

  • Introduced sample-specific network perturbation analysis (ssNPA), a method that learns causal graphs from control data.
  • Quantified sample-specific network neighborhood deregulation using prediction errors from Markov blankets.
  • Evaluated ssNPA on single-cell RNA-seq liver development data and TCGA datasets.

Main Results:

  • ssNPA successfully recovered cell timing in liver development data.
  • ssNPA identified patient clusters with significant survival differences in TCGA datasets.
  • ssNPA consistently outperformed alternative methods across all analyses.

Conclusions:

  • Network-based approaches, like ssNPA, offer advantages for analyzing complex diseases.
  • ssNPA provides a robust method for subtyping samples based on gene network deregulation.
  • This approach facilitates patient-specific identification of disease mechanisms and personalized treatment strategies.